Despite many people in the U.S. being cannabis users, these people are often excluded from receiving liver transplants, a potentially life-saving procedure.
Scientists and experts have historically had concerns regarding cannabis’s role in the body. In the case of liver transplants, there’s a concern that cannabis might create a bigger risk for infections.
Researchers analyzed the data from 111 patients who were also cannabis users. Only 32 of them received a liver transplant. Researchers compared users who received a liver transplant with non-users who received the same procedure and found no statistical difference between the two.
Salon explains that fungal infections are often a concern when talking about liver transplants, especially in the case of Aspergillus, a fungus that’s also present in the cannabis plant. “The fear is that by ingesting a cannabis product contaminated by Aspergillus, it would complicate the transplant, resulting in failure or death.”
Read full article on The Growth Op
